Board's proposal for redemption of shares in Elekta
BOARD'S PROPOSAL FOR REDEMPTION OF SHARES IN ELEKTA· The Board proposes a redemption of every seventeenth share for SEK 165 per share· Through the redemption, approximately SEK 319.8 million is proposed to be transferred to the shareholdersThe Board of Directors of Elekta AB (publ) has today established theconditions for its proposal regarding redemption of shares to the AnnualGeneral Meeting to be held on September 22, 2003. According to theproposal, every seventeenth share may be redeemed for SEK 165 in cash.For every share held in Elekta, one redemption right will be received.Seventeen redemption rights entitle the holder to redeem one share.Assuming full acceptance of the redemption offer, approximately 1.9million shares will be redeemed and approximately SEK 319.8 milliontransferred to the shareholders in Elekta.Time table (assuming the Annual General Meeting's approval):Last day of trading shares in Elektaincluding redemption rights: September 30, 2003First day of trading shares in Elektaexcluding redemption rights : October 1, 2003Record date for receiving redemption rights: October 3, 2003Information brochure and applicationform distributed: October 8, 2003Application period: October 13 - November 11, 2003Trading in redemption rights onStockholmsbörsen October 13 - November 6, 2003A sale of up to 2,000 redemption rights free of commission will beprovided through D. Carnegie AB ("Carnegie") during October 13 - October31, 2003 following a specific application procedure. Before payment ofthe redemption proceeds can be made, the court's permission must beobtained and the permission registered with the Swedish Patent andRegistration Office, which is estimated to take place at the end ofMarch 2004.Carnegie is the financial advisor to Elekta AB in connection with theredemption offer. ***********For further information, please contact:Shareholders who whish to receive further information regarding theapplication procedure etc. in the redemption offer, may call Carnegie'stransaction support at +46 8 588 694 81.Other inquiries:Peter Ejemyr, Group VP Corporate Communications, Elekta AB (publ),Phone: +46 8 587 254 00, e-mail: [email protected] is a world-leading supplier of advanced and innovative radiationoncology and neurosurgery solutions and services for precise treatmentof cancer and brain disorders. Elekta's solutions are clinicallyeffective, cost efficient and gentle to the patient.For additional information about Elekta, visit www.elekta.com------------------------------------------------------------This information was brought to you by Waymaker http://www.waymaker.netThe following files are available for download:http://www.waymaker.net/bitonline/2003/09/12/20030912BIT00170/wkr0001.doc http://www.waymaker.net/bitonline/2003/09/12/20030912BIT00170/wkr0002.pdf